{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T20:33:59Z","timestamp":1778963639460,"version":"3.51.4"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.schres.2023.01.019","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T12:31:06Z","timestamp":1674649866000},"page":"300-308","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan"],"prefix":"10.1016","volume":"252","author":[{"given":"Yusuke","family":"Okada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Inada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manabu","family":"Akazawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0005","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1001\/jama.288.4.455","article-title":"Long-term persistence in use of statin therapy in elderly patients","volume":"288","author":"Benner","year":"2002","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41537-021-00192-x","article-title":"Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics","volume":"8","author":"Correll","year":"2022","journal-title":"Schizophrenia"},{"issue":"10 Suppl. 2","key":"10.1016\/j.schres.2023.01.019_bb0015","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1097\/MLR.0b013e31806518ac","article-title":"Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases","volume":"45","author":"Curtis","year":"2007","journal-title":"Med. Care"},{"issue":"6","key":"10.1016\/j.schres.2023.01.019_bb0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179049","article-title":"Treatment continuation of four long-acting antipsychotic medications in the Netherlands and Belgium: a retrospective database study","volume":"12","author":"Decuypere","year":"2017","journal-title":"PLoS One"},{"issue":"446","key":"10.1016\/j.schres.2023.01.019_bb0025","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"2","key":"10.1016\/j.schres.2023.01.019_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/sim.4780110208","article-title":"A semi-Bayes approach to the analysis of correlated multiple associations, with an application to an occupational cancer-mortality study","volume":"11","author":"Greenland","year":"1992","journal-title":"Stat. Med."},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/ppe.12711","article-title":"Analysis goals, error-cost sensitivity, and analysis hacking: essential considerations in hypothesis testing and multiple comparisons","volume":"35","author":"Greenland","year":"2021","journal-title":"Paediatr. Perinat. Epidemiol."},{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0040","doi-asserted-by":"crossref","DOI":"10.2196\/21622","article-title":"Effects of an mHealth app (Kencom) with integrated functions for healthy lifestyles on physical activity levels and cardiovascular risk biomarkers: observational study of 12,602 users","volume":"23","author":"Hamaya","year":"2021","journal-title":"J. Med. Internet Res."},{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0045","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1177\/2045125312474019","article-title":"Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review","volume":"3","author":"Higashi","year":"2013","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"10202","key":"10.1016\/j.schres.2023.01.019_bb0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.schres.2023.01.019_bb0055","first-page":"586","article-title":"Assessing outcomes between risperidone microspheres and paliperidone palmitate long-acting injectable antipsychotics among veterans","volume":"38","author":"Ibrahim","year":"2021","journal-title":"Fed. Pract."},{"issue":"8","key":"10.1016\/j.schres.2023.01.019_bb0060","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/pcn.12275","article-title":"Psychotropic dose equivalence in Japan","volume":"69","author":"Inada","year":"2015","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/pcn.13304","article-title":"Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study","volume":"76","author":"Ishigooka","year":"2022","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.schres.2023.01.019_bb0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/npr2.12193","article-title":"Japanese Society of Neuropsychopharmacology: \"Guideline for pharmacological therapy of Schizophrenia\"","volume":"41","year":"2021","journal-title":"Neuropsychopharmacol. Rep."},{"issue":"11","key":"10.1016\/j.schres.2023.01.019_bb0075","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1080\/03007995.2016.1219706","article-title":"Healthcare resource utilization of second-generation long-acting injectable antipsychotics in schizophrenia: risperidone versus paliperidone palmitate","volume":"32","author":"Joshi","year":"2016","journal-title":"Curr. Med. Res. Opin."},{"issue":"11","key":"10.1016\/j.schres.2023.01.019_bb0080","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.4088\/JCP.v64n1105","article-title":"Partial compliance and patient consequences in schizophrenia: our patients can do better","volume":"64","author":"Keith","year":"2003","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2023.01.019_bb0085","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2188\/jea.JE20090066","article-title":"Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage","volume":"20","author":"Kimura","year":"2010","journal-title":"J. Epidemiol."},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0090","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2011.143","article-title":"Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics","volume":"18","author":"Kishimoto","year":"2013","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.schres.2023.01.019_bb0095","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2215-0366(21)00039-0","article-title":"Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre-post studies","volume":"8","author":"Kishimoto","year":"2021","journal-title":"Lancet Psychiatry"},{"issue":"10","key":"10.1016\/j.schres.2023.01.019_bb0100","doi-asserted-by":"crossref","first-page":"892","DOI":"10.4088\/JCP.v63n1007","article-title":"Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature","volume":"63","author":"Lacro","year":"2002","journal-title":"J. Clin. Psychiatry."},{"key":"10.1016\/j.schres.2023.01.019_bb0105","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.2147\/NDT.S286654","article-title":"Effect of paliperidone palmitate 3-month formulation on goal attainment and disability after 52 weeks' treatment in patients with clinically stable schizophrenia","volume":"16","author":"Lambert","year":"2020","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"12","key":"10.1016\/j.schres.2023.01.019_bb0110","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1176\/ps.2010.61.12.1239","article-title":"Medication adherence and hospitalization among patients with schizophrenia treated with antipsychotics","volume":"61","author":"Lang","year":"2010","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.pnpbp.2011.02.001","article-title":"A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia","volume":"35","author":"Li","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/JCP.0000000000000827","article-title":"Comparison of paliperidone palmitate and risperidone long-acting injection in schizophrenic patients: results from a multicenter retrospective cohort study in France","volume":"38","author":"Limosin","year":"2018","journal-title":"J. Clin. Psychopharmacol."},{"issue":"19","key":"10.1016\/j.schres.2023.01.019_bb0125","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.2014.4310","article-title":"Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial","volume":"311","author":"McEvoy","year":"2014","journal-title":"JAMA"},{"issue":"1\u20132","key":"10.1016\/j.schres.2023.01.019_bb0130","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.schres.2015.07.007","article-title":"Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia","volume":"168","author":"Naber","year":"2015","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2023.01.019_bb0135","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1093\/schbul\/sbu128","article-title":"Comparative effectiveness of risperidone long-acting injectable vs first-generation antipsychotic long-acting injectables in schizophrenia: results from a nationwide, retrospective inception cohort study","volume":"41","author":"Nielsen","year":"2015","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2023.01.019_bb0140","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.pnpbp.2010.11.008","article-title":"A double-blind study of paliperidone palmitate and risperidone long-acting injectable in adults with schizophrenia","volume":"35","author":"Pandina","year":"2011","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2023.01.019_bb0145","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"issue":"3","key":"10.1016\/j.schres.2023.01.019_bb0150","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpsyc.56.3.241","article-title":"Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder","volume":"56","author":"Robinson","year":"1999","journal-title":"Arch. Gen. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0155","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","article-title":"Size of burden of schizophrenia and psychotic disorders","volume":"15","author":"R\u00f6ssler","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"issue":"5","key":"10.1016\/j.schres.2023.01.019_bb0160","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1080\/00048670801961107","article-title":"Partial compliance with antipsychotic medication is common in patients with schizophrenia","volume":"42","author":"Rummel-Kluge","year":"2008","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2023.01.019_bb0165","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2147\/NDT.S41632","article-title":"The cost of schizophrenia in Japan","volume":"9","author":"Sado","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.schres.2023.01.019_bb0170","first-page":"25","article-title":"Management of antipsychotic treatment discontinuation and interruptions using model-based simulations","volume":"4","author":"Samtani","year":"2012","journal-title":"Clin. Pharmacol."},{"issue":"4","key":"10.1016\/j.schres.2023.01.019_bb0175","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5582\/bst.2021.01194","article-title":"The impact of COVID-19 pandemic on the utilization of ambulatory care for patients with chronic neurological diseases in Japan: evaluation of an administrative claims database","volume":"15","author":"Sato","year":"2021","journal-title":"Biosci. Trends"},{"issue":"12","key":"10.1016\/j.schres.2023.01.019_bb0180","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/2045125318795130","article-title":"First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse","volume":"8","author":"Stone","year":"2018","journal-title":"Ther. Adv. Psychopharmacol."},{"issue":"6","key":"10.1016\/j.schres.2023.01.019_bb0185","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1093\/schbul\/sbx176","article-title":"Comparative effectiveness of antipsychotic drugs for rehospitalization in schizophrenia-a nationwide study with 20-year follow-up","volume":"44","author":"Taipale","year":"2018","journal-title":"Schizophr. Bull."},{"issue":"7","key":"10.1016\/j.schres.2023.01.019_bb0190","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jamapsychiatry.2017.1322","article-title":"Real-world effectiveness of antipsychotic treatments in a nationwide cohort of 29 823 patients with schizophrenia","volume":"74","author":"Tiihonen","year":"2017","journal-title":"JAMA Psychiatry"},{"issue":"1\u20132","key":"10.1016\/j.schres.2023.01.019_bb0195","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2016.02.037","article-title":"Comparison of treatment effectiveness and medical costs for different long-acting injectable antipsychotics in patients with schizophrenia in Taiwan: a nationwide population-based cohort study","volume":"173","author":"Wu","year":"2016","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996423000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:53:59Z","timestamp":1760298839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996423000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":39,"alternative-id":["S0920996423000312"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2023.01.019","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness of long-acting injectable antipsychotics in patients with schizophrenia in Japan","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2023.01.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}